Tumor marker protein for cancer risk assessment

Details Tumor marker protein for cancer risk assessment Tumor marker protein for cancer risk assessment

1995-03-17

1998-06-30

Woodward, Miichael P.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435 723, 435 693, 536 235, 530352, 530358, 5303588, 53038885, 5303897, 530828, C12Q 168, G01N 33574

Patent

active

057732159

ABSTRACT:
This invention relates to the isolation, identification and sequencing of a cancer associated protein, preparation of hybridization probes therefrom, preparation of antibodies thereto, and methods of cancer risk assessment and diagnosis.

REFERENCES:
patent: 4448890 (1984-05-01), Smetana et al.
patent: 4746539 (1988-05-01), Webb et al.
Result 7, "Human Retinoic Acid Receptor . . . " M57707.
Hanausek-Walaszk et al., "Carcinogenesis," Proceedings of the American Association for Cancer Research 30:190, Abstract 754 (1989).
Larroya et al., "Immunology," Proceedings of the American Association for Cancer Research 30:349, Abstract 1385 (1989).
Hanausek-Walaszek et al., "Carcinogenesis," Proceedings of AACR 29:167, Abstract 665 (1988).
Hanausek-Walaszek et al., "Correspondence Between Biochemical and Antigenic Activity of a 60 Kilodalton Oncofetal Protein During Carcinogenesis and Tumorigenesis," Cancer Letters 33:55-61 (1986).
Hanausek-Walaszek et al., "A 60 Kilodalton Oncofetal Protein As Tumor Marker," J. Med. 17:13-23 (1986).
Schroder et al., "Proteins from rat lover cytosol which stimulate mRNA transport," Eur. J. Biochem. 159:51-59 (1986).
Hanausek-Walaszek et al., "Immunological Identity of a 60 KD Onmcofetal Protein Induced in Rats by Chemical Carcinogens and Released by Transformed Cells," BBRC 127:779-785 (1985).
Hanusek-Walaszek et al., "Chemical carcinogens as specific inducers of a 60-kilodalton oncofetal protein in rats," Carcinogenesis 7:1725-1730 (1985).
Schumm et al., "Abscence of the Cancer-Associated Factor with a Molecular Weight of 60,000 from the Plasma of Patients with a Spectrum of Nonneoplastic Conditions," Cancer Res. 44:401-406 (1984).
Hanausek-Walaszek et al., "Characterization of a 60,000-dalton Oncofetal Protein from the Plasma of Tumor-Bearing Rats," Cancer Invest. 2:433-441 (1984).
French et al., "Nucleocytoplasmic Release of Repetitive DNA Transcripts in Carcinogenesis Correlates with a 60 Kilodalton Cytoplasmic Protein," Cancer Letters 23:45-52 (1984).
Walaszek et al., "An Oncofetal 60-Kilodalton Protein in the Plasma of Tumor-Bearing and Carcinogen-Treated Rats," Cancer Letters 20:277-282 (1983).
Hanausek-Walaszek et al., "Structural and Immunological Identity of p65 Tumor-Associated Factors from Rat and mouse Hepatocarcinomas," Progress in Clinical and Biological Research (1989).
Mirowski et al., "Purification and Characterization of a 65-kDa Tumor-Associated Phosphoprotein from rat Transplantable Hepatocellular Carcinoma 1682C Cell Line," Protein Exp. and Pur. 3:196-203 (1992).
Wang et al., "Monoclonal Antibodies Against a 65-kDa Tumor-Associated Phosphoprotein: Development and Use in Cancer Detection," Hybridoma 12:167-176 (1993).
Mirowski et al., "Demonstration of a 65 kDa Tumor-Specific Phospho-protein in Urine and Serum of Rats with N-methyl-N-nitrosourea-induced Mammary Adenocarcinomas," Carcinogenesis 14:1659-1664 (1993).
Mirowski et al., "Comparative Structural Analysis of Human and Rat 65 kDa Tumor-Associated Phosphoproteins," Int. J. Biochem. 25:1865-1871 (1993).
Del Rio et al., "Expression of a 65 kDa Oncofetal Phosphoprotein in the Altered Hepaic Foci of Rats Fed 2-Acetylaminofluorene Followed by Phenobarbital," Int. J. Oncol. 5:259-265 (1994).
Mirowski et al., "Serological and Immunohistochemical Detection of a 65-kDa Oncofetal Protein in Breast Cancer," European Journal of Cancer 30A:1108-1113 (1994).
Hanausek et al., "The Oncofetal Protein p65 as a New Member of the Steroid/Thyroid Receptor Superfamily," Cancer Detection and Prevention 19:1995, Abstract 118/307 307 (1995).
Mirowski et al., "Isolation of the 65 kDa Oncofetal Phosphoprotein from Fetal Bovine Serum, Polyclonal Antibody Production and use in Cancer Detection," AACR (/toronto, Mar. 20, 1995).
Hanausek et al., "The Oncofetal Protein p65 as a Member of the Steroid/Thyroid Receptor Superfamily: Relevance to Breast Cancer," AACR (Toronto, Mar. 20, 1995).

Affiliated with

Also associated with

Rating

Tumor marker protein for cancer risk assessment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor marker protein for cancer risk assessment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor marker protein for cancer risk assessment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1857553